Scleroderma Clinical Trials Consortium INC's annual revenue was $326K in tax year 2024, reported on their IRS Form 990. They spent $299K in total expenses. 96% went to programs and services.
Scleroderma Clinical Trials Consortium INC spent $299K in tax year 2024, according to their IRS Form 990 filing.
Scleroderma Clinical Trials Consortium INC spent $287K (96% of expenses) on programs and services in tax year 2024.
Scleroderma Clinical Trials Consortium INC's overhead in tax year 2024 includes administrative (4%) and fundraising (0%) of their expenses.
Scleroderma Clinical Trials Consortium INC had net assets of $4.0M as of the end of tax year 2024.
Track Scleroderma Clinical Trials Consortium INC
Support to get their new filings, financial changes and grants as they post.
Leave your email and we’ll let you know when you can finish signing in and follow the organization.
Try signing in anyway →